M, Cattaneo D, Nobile M, et al. Potential Benefits and Limits of Psychopharmacological Therapies in Pervasive Developmental Disorders. Curr Clin Pharmacol. 2013 Sep 20PMID: 24050744; X-5 2327. Molteni P, Guldberg K, Logan N. Autism and multidisciplinary teamwork through the SCERTS model. British Journal of Special Education. 2013;40(3):137-45. X-1, X-3, X-4 2328. Monahan M, Classen S, Helsel PV. Pre-driving evaluation of a teen with attention deficit hyperactivity disorder and autism spectrum disorder. Can J Occup Ther. 2013 Feb;80(1):35-41. PMID: 23550495; X-5 2329. Moore DW, Venkatesh S, Anderson A, et al. TOBY play-pad application to teach children with ASD - A pilot trial. Dev Neurorehabil. 2013 Jul 19PMID: 23869435; X-1, X-4 2330. Moran MF, Foley JT, Parker ME, et al. Two-legged hopping in autism spectrum disorders. Front Integr Neurosci. 2013;7:14. PMID: 23532337; X-5 2331. Moss J, Oliver C, Nelson L, et al. Delineating the profile of autism spectrum disorder characteristics in Cornelia de Lange and Fragile X syndromes. Am J Intellect Dev Disabil. 2013 Jan;118(1):55-73. PMID: 23301903; X-5 2332. Moyal WN, Lord C, Walkup JT. Quality of Life in Children and Adolescents with Autism Spectrum Disorders: What Is Known About the Effects of Pharmacotherapy? Paediatr Drugs. 2013 Oct 24PMID: 24155138; X-1, X-2, X-3, X-4 2333. Mucchetti CA. Adapted shared reading at school for minimally verbal students with Autism. Autism. 2013 May 2013;17(3):358-72. X-3, X-4 2334. Mukherjee S, Rupani K, Dave M, et al. Evaluation of Effectiveness of Integrated Intervention in Autistic Children. Indian J Pediatr. 2013 Sep 21PMID: 24057967; X-5 2335. Mulligan CK, Trauner DA. Incidence and Behavioral Correlates of Epileptiform Abnormalities in Autism Spectrum Disorders. J Autism Dev Disord. 2013 Jul 20PMID: 23872941; X-5 2336. Murray KE, Nyp SS, Wassom MC. Journal article reviews. Journal of Developmental and Behavioral Pediatrics. 2013;34(2):141-5. X-5 E-98 2337. Murray ML, Hsia Y, Glaser K, et al. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology (Berl). 2013 May 17PMID: 23681164; X-1, X-3, X-4 2338. Myers CL, Gross AD, McReynolds BM. Broadband Behavior Rating Scales as Screeners for Autism? J Autism Dev Disord. 2013 Nov 28PMID: 24287879; X-5 2339. Naber FB, Poslawsky IE, van Ijzendoorn MH, et al. Brief Report: Oxytocin Enhances Paternal Sensitivity to a Child with Autism--A Double-Blind Within-Subject Experiment with Intranasally Administered Oxytocin. Journal of Autism and Developmental Disorders. 2013;43(1):224-9. X-5 2340. Narayanan S, Georgiou PG. Behavioral Signal Processing: Deriving Human Behavioral Informatics From Speech and Language: Computational techniques are presented to analyze and model expressed and perceived human behavior-variedly characterized as typical, atypical, distressed, and disordered-from speech and language cues and their applications in health, commerce, education, and beyond. Proc IEEE Inst Electr Electron Eng. 2013 Feb 7;101(5):1203-33. PMID: 24039277; X-5 2341. Narcisa V, Discenza M, Vaccari E, et al. Parental interest in a genetic risk assessment test for autism spectrum disorders. Clin Pediatr (Phila). 2013 Feb;52(2):139-46. PMID: 23193169; X-5 2342. Narzisi A, Colombi C, Balottin U, et al. Non- Pharmacological Treatments in Autism Spectrum Disorders: An Overview on Early Interventions for Pre-schoolers. Curr Clin Pharmacol.